cbdMD, Inc.
YCBD
$0.85
$0.011.59%
AMEX
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.47% | -3.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.47% | -3.00% | |||
| Cost of Revenue | 9.46% | -0.80% | |||
| Gross Profit | -1.90% | -4.34% | |||
| SG&A Expenses | -4.94% | 3.40% | |||
| Depreciation & Amortization | -6.46% | -1.99% | |||
| Other Operating Expenses | -32.78% | 143.44% | |||
| Total Operating Expenses | -1.90% | 5.28% | |||
| Operating Income | 24.20% | -86.23% | |||
| Income Before Tax | 24.05% | -86.21% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 24.05% | -86.21% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 24.05% | -86.21% | |||
| EBIT | 24.20% | -86.23% | |||
| EBITDA | 32.14% | -212.41% | |||
| EPS Basic | 64.28% | 88.83% | |||
| Normalized Basic EPS | 51.03% | 74.79% | |||
| EPS Diluted | 64.28% | 88.83% | |||
| Normalized Diluted EPS | 51.03% | 74.79% | |||
| Average Basic Shares Outstanding | 54.96% | 642.99% | |||
| Average Diluted Shares Outstanding | 54.96% | 642.99% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||